Co. Ltd. has patented new tricyclic compounds acting as serine/threonine-protein kinase ATR inhibitors and thus reported to be useful for the treatment of colon cancer.
University of Eastern Finland, Kuopio, Finland. Tousled-like kinase 2 (TLK2) is a ubiquitously expressed, nuclear serine/threonine kinase. The kinase activity of TLK2 and its closest human ...